[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Enveric Biosciences Inc (ENVB)

Enveric Biosciences Inc (ENVB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 4,786
  • Shares Outstanding, K 3,682
  • Annual Sales, $ 0 K
  • Annual Income, $ -8,770 K
  • EBIT $ -8 M
  • EBITDA $ -8 M
  • 60-Month Beta 1.11
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 0.58

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.2900 +1.55%
on 06/17/26
2.4100 -45.64%
on 05/29/26
-0.8400 (-39.07%)
since 05/18/26
3-Month
1.2900 +1.55%
on 06/17/26
7.8800 -83.38%
on 04/24/26
-0.7000 (-34.83%)
since 03/18/26
52-Week
1.2900 +1.55%
on 06/17/26
17.6400 -92.57%
on 08/27/25
-13.8100 (-91.34%)
since 06/18/25

Most Recent Stories

More News
Enveric Biosciences Announces Participation in 2026 BIO International Convention

Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company advancing novel neuroplastogenic small-molecule therapeutics to address psychiatric and neurological...

ENVB : 1.3050 (+0.38%)
Enveric Biosciences to Participate in the UBS 3rd Virtual CNS Day

Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company advancing novel neuroplastogenic small-molecule therapeutics to address psychiatric and neurological...

ENVB : 1.3050 (+0.38%)
Enveric Biosciences Initiates Investigational New Drug (IND)-enabling Genotoxicity Studies of Lead Neuroplastogen Candidate EB-003

Studies are designed to evaluate the potential for the compound to interact with DNA and cause genetic mutations, a critical measure of safety required for IND submission

ENVB : 1.3050 (+0.38%)
Enveric Biosciences Reports Positive Preclinical Results from Phototoxicity Analysis for Lead Neuroplastogen Candidate EB-003

Analysis showed no photoreactive potential for EB-003, further derisking its continued development for the treatment of neuropsychiatric disorders including depression, anxiety and PTSD. ...

ENVB : 1.3050 (+0.38%)
Enveric Biosciences Reports Financial Results and Provides Corporate Update for First Quarter 2026

Product Development Highlights: Continued advancement of lead candidate EB-003 with IND-enabling studies progressing toward planned first-in-human...

ENVB : 1.3050 (+0.38%)
Enveric Biosciences Expands IP Portfolio with New U.S. Patent Issued for Methods of Treating Psychiatric Disorders

Claims to methods for treating a psychiatric disorder using novel pharmaceutical drug formulations encompass an EVM301 Series of drug candidates of carboxylated psilocybin derivatives, targeting various...

ENVB : 1.3050 (+0.38%)
Enveric Biosciences Highlights Positive Results for EB-003 in PTSD Preclinical Model

Previously reported results support continued development of EB-003 for PTSD and other neuropsychiatric conditions Recent U.S. Executive Order supporting psychedelic-inspired...

ENVB : 1.3050 (+0.38%)
Lakewood-Amedex Biotherapeutics Appoints Joseph Tucker, Ph.D., to Board of Directors

Appointment strengthens Board with seasoned public company biotech executive following recent Nasdaq direct listing

LABT : 0.5595 (-7.09%)
ENVB : 1.3050 (+0.38%)
Enveric Biosciences to Participate in a Panel Discussion at Needham’s Virtual Psychedelics Forum

Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company advancing novel neuroplastogenic small-molecule therapeutics to address psychiatric and neurological...

ENVB : 1.3050 (+0.38%)
Enveric Biosciences Announces Closing of Up To $13.9 Million Private Placement Priced At-The-Market Under Nasdaq Rules

$5 million upfront with up to approximately $8.9 million of potential aggregate proceeds upon the exercise in full of warrants

ENVB : 1.3050 (+0.38%)

Business Summary

Enveric Biosciences Inc. is a patient-centric biotechnology company endeavoring to enhance the lives of Cancer Treatments with novel cannabinoid medicines. Enveric Biosciences Inc., formerly known as AMERI Holdings Inc., is based in NAPLES, Fla.

See More

Key Turning Points

3rd Resistance Point 1.4300
2nd Resistance Point 1.4000
1st Resistance Point 1.3500
Last Price 1.3050
1st Support Level 1.2700
2nd Support Level 1.2400
3rd Support Level 1.1900

See More

52-Week High 17.6400
Fibonacci 61.8% 11.3943
Fibonacci 50% 9.4650
Fibonacci 38.2% 7.5357
Last Price 1.3050
52-Week Low 1.2900

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.